How trait variation in TREM2 impacts different phases of the AD pathological cascade is yet to be fully elucidated in humans and offers an approach to study how dysfunctional TREM2 impacts microglial functions leading to increased burden of Aβ and tau. Here, MAPT is linked to Alzheimer disease.